Global Quality GMP Audits in China: meeting FDA, EMA, and NMPA standards

As global supply chains expand, pharmaceutical and biotechnology companies operating internationally must satisfy multiple regulatory frameworks at once. Verta supports that need by delivering GMP audits in China that align with local regulations and the expectations of the U.S. FDA and EU EMA.

The goal is practical: help clients maintain compliance across major markets without forcing global quality teams to choose between local execution and international inspection readiness.

Meeting U.S. FDA, EU EMA, and Chinese GMP standards

Manufacturers in China increasingly supply products to the United States and European Union, making alignment with FDA and EMA expectations critical. At the same time, compliance with China’s National Medical Products Administration (NMPA) remains essential for local operations.

• U.S. FDA cGMP requirements, including 21 CFR Parts 210 and 211
• EU GMP guidelines, including EudraLex Volume 4
• Chinese GMP regulations and NMPA expectations

Verta’s audit approach is built to address all three frameworks simultaneously, so findings are useful for global regulatory scrutiny rather than only local compliance.

Local expertise with a global perspective

Our China-based QA consultants bring deep knowledge of Chinese GMP requirements while remaining fully versed in FDA and EU expectations. That dual capability helps identify gaps that may not be apparent when audits are conducted solely against local standards.

By understanding how global regulators interpret data integrity, quality systems, and manufacturing controls, audit teams can anticipate real-world inspection scenarios before they become submission or supply risks.

Comprehensive GMP audit coverage

• Quality Management Systems aligned with FDA and EU expectations
• Data integrity practices in line with global regulatory focus areas
• Manufacturing processes, facility controls, and validation
• Supplier qualification for global supply chains
• Documentation and record-keeping standards required for international submissions

Each audit results in clear, actionable findings prioritized by regulatory risk, helping clients address compliance gaps efficiently and communicate next steps across regions.

Bridging global and local teams

Effective communication is critical when navigating multi-regional compliance. Verta’s bilingual consultants support collaboration between Chinese manufacturing sites and global quality teams, with reporting that reflects FDA and EU terminology and expectations.

Driving global inspection readiness

At Verta, GMP audits go beyond basic compliance checks. We help organizations build robust, inspection-ready systems capable of withstanding scrutiny from U.S. FDA, EU authorities, and Chinese regulators alike.

For organizations sourcing or manufacturing in China and targeting U.S. or EU markets, Verta provides comprehensive, globally aligned GMP auditing backed by local execution and international regulatory perspective.

For help applying this expertise to your program, contact Verta.